Jump to content
Sclero Forums
Sign in to follow this  
Joelf

IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis (SSc).

Recommended Posts

IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis (SSc).

 

Hypomethylation of the IRF7 promoter might play a role in SSc pathogenesis, probably through promoting the IRF7 expression in peripheral blood mononuclear cells of patients with SSc. PubMed, Int J rheumatologist Dis, 09/26/2017. (Also see Cytokines)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Board Member

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×